Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Bliss GVS Pharma Ltd. market cap is 12.24B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bliss GVS Pharma Ltd. 52 week high is 149.60 as of April 26, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bliss GVS Pharma Ltd. 52 week low is 70.85 as of April 26, 2024.
Bliss GVS Pharma Ltd. stock price today is 123.10.
Bliss GVS Pharma Ltd. stock price yesterday was 116.55.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bliss GVS Pharma Ltd.’s P/E ratio is 13.90.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Bliss GVS Pharma Ltd. P/B ratio is 1.3128.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Bliss GVS Pharma Ltd.'s EBITDA is 7.15.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Bliss GVS Pharma Ltd. 50-day moving average is 117.42.
Bliss GVS Pharma Ltd. has 763 employees.